Back to Search Start Over

OncoSec initiates Phase II Merkel cell carcinoma study and doses several patients

Source :
Chemical Business Newsbase. February 13, 2012
Publication Year :
2012

Abstract

OncoSec Medical Inc (OncoSec), which is developing its advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumour cancers, announced that physicians at the University of Washington and Seattle [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Chemical Business Newsbase
Publication Type :
News
Accession number :
edsgcl.280711879